Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.
|Bias||Author's judgement||Support for judgement|
|Quote: “Patients were block-randomized to receive either 16-hour traditional or 24-hour prolonged prone positioning followed by a supine session”
Comment: Allocation sequence random.
No information on allocation concealment
|Deviations from intervention||
|Quote: “None (Open Label)”
Comment: Unblinded study (participants and personnel/carers)
Deviations from intended intervention arising because of the study context:
No participant cross-over.
No information on administration of co-interventions of interest: antivirals, corticosteroids or biologics.
Hence, no information on whether deviations arose because of the trial context.
Our analysis for the binary outcome is an intention-to-treat analysis. This method was considered appropriate to estimate the effect of assignment to intervention.
Risk assessed to be some concerns for the outcomes: Mortality (D28). Clinical improvement (D28).
|Missing outcome data||
|Comment: 52 participants randomized; 52 participants analyzed.
Data available for all participants randomized.
Risk assessed to be low for the outcomes: Mortality (D28). Clinical improvement (D28).
|Measurement of the outcome||
|Comment: Method of measuring the outcome probably appropriate.
Measurement or ascertainment of outcome probably does not differ between groups.
Unblinded study (outcome assessor)
Observer-reported outcome not involving judgement.
Risk assessed to be low for the outcomes: Mortality (D28).
Clinical improvement (defined as discharge) requires clinical judgement and could be affected by knowledge of intervention receipt, but it not considered likely to in the context of a pandemic.
Risk assessed to be some concerns for the outcomes: Clinical improvement (D28).
|Selection of the reported results||
|Comment: The registry was available (dated October 9, 2020).
Results were not selected from multiple outcome measurements or analyses of the data.
Trial analyzed as pre-specified.
Risk assessed to be low for the outcome: Mortality (D28).Clinical improvement (D28).
|Overall risk of bias||